Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation
A Nörthen, T Asendorf, PD Walson, M Oellerich - Clinical biochemistry, 2018 - Elsevier
Abstract Background Alpha-1-fetoprotein (AFP) is used to monitor progression, evaluate
response to therapy and predict recurrence of hepatocellular carcinoma (HCC) in liver …
response to therapy and predict recurrence of hepatocellular carcinoma (HCC) in liver …
[PDF][PDF] Serum alpha‐fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma
K Berry, GN Ioannou - Liver Transplantation, 2013 - Wiley Online Library
We aimed to determine whether combining serum alpha‐fetoprotein (AFP) level with
hepatocellular carcinoma (HCC) tumor burden would allow better stratification of …
hepatocellular carcinoma (HCC) tumor burden would allow better stratification of …
The value of serum α-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
Background Many patients with hepatocellular carcinoma (HCC) who undergo liver
transplantation (LT) subsequently develop tumor recurrence; this is the main factor affecting …
transplantation (LT) subsequently develop tumor recurrence; this is the main factor affecting …
[PDF][PDF] Combinations of biomarkers and M ilan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation
R Chaiteerakij, X Zhang, BD Addissie… - Liver …, 2015 - Wiley Online Library
Growing evidence suggests that pretransplant alpha‐fetoprotein (AFP) predicts outcomes of
hepatocellular carcinoma (HCC) patients treated with liver transplantation. We aimed to …
hepatocellular carcinoma (HCC) patients treated with liver transplantation. We aimed to …
[HTML][HTML] Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma
B Charrière, C Maulat, B Suc… - World journal of …, 2016 - ncbi.nlm.nih.gov
Alpha-fetoprotein (AFP) is the main tumor biomarker available for the management of
hepatocellular carcinoma (HCC). Although it is neither a good screening test nor an …
hepatocellular carcinoma (HCC). Although it is neither a good screening test nor an …
[HTML][HTML] The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution
The role of alpha-fetoprotein (AFP) in the specific setting of the diagnosis and prognosis of
patients with hepatocellular cancer (HCC) waiting for liver transplantation (LT) is still …
patients with hepatocellular cancer (HCC) waiting for liver transplantation (LT) is still …
Pre‐transplant alpha‐fetoprotein is associated with post‐transplant hepatocellular carcinoma recurrence mortality
Background Although liver transplantation may potentially cure hepatocellular carcinoma
(HCC), the risk of HCC recurrence is 8%‐20% at five years post‐transplant. Pre‐transplant …
(HCC), the risk of HCC recurrence is 8%‐20% at five years post‐transplant. Pre‐transplant …
[HTML][HTML] Peri-transplant change in AFP level: A useful predictor of hepatocellular carcinoma recurrence following liver transplantation
Pretransplant alpha-fetoprotein (AFP) is a useful tumor marker predicting recurrence of
hepatocellular carcinoma (HCC). Little is known, however, about the relationship between …
hepatocellular carcinoma (HCC). Little is known, however, about the relationship between …
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation
Background & Aims Alpha-fetoprotein (AFP) predicts hepatocellular carcinoma (HCC)
recurrence after liver transplant (LT) but remains an imperfect biomarker. The role of DCP …
recurrence after liver transplant (LT) but remains an imperfect biomarker. The role of DCP …
Evaluation of absolute serum α-fetoprotein levels in liver transplant for hepatocellular cancer
B Mailey, A Artinyan, J Khalili, J Denitz… - Archives of …, 2011 - jamanetwork.com
Hypothesis An elevated serum α-fetoprotein (AFP) level before orthotopic liver transplant
(OLT) is predictive of mortality after OLT for hepatocellular carcinoma (HCC). Design …
(OLT) is predictive of mortality after OLT for hepatocellular carcinoma (HCC). Design …